Pentagastrin C37H49N7O9S is a synthetic peptide composed of five amino acids, mainly used for diagnostic drugs, such as gastric secretion function tests and pancreatic function tests.
Its market applications are mainly reflected in the following aspects
Diagnostic application: It is mainly used for checking the secretion function of gastric acid, observing the secretion of gastric acid through subcutaneous or intramuscular injection, thereby helping doctors judge the patient's gastric function status. In addition, pentagastrin can also be used for pancreatic function testing to understand the functional status of the pancreas by stimulating its secretion of pancreatic juice.
Therapeutic application: pentagastrin injection can stimulate the absorption of electrolytes, glucose, and other nutrients in the small intestine, increase their reabsorption, and help treat gastrointestinal ulcer bleeding, chronic pancreatitis, and obstructive jaundice in patients after pancreatectomy.
Pentagastrin is a gastrointestinal hormone secreted by adenosine cyclase in the small intestine mucosa. It has various physiological effects, including promoting gastric acid secretion, promoting gastrointestinal peristalsis, improving indigestion, maintaining blood sugar balance, and protecting the gastric mucosa. For patients with gastroesophageal reflux disease, the effect of pentagastrin on their esophageal motility is mainly reflected in the change of pressure on the lower esophageal sphincter (LES).
Injection of pentagastrin can significantly increase the pressure on the lower esophageal sphincter. This increase in pressure helps to reduce the possibility of gastric acid reflux into the esophagus, thereby alleviating the symptoms of gastroesophageal reflux. However, pentagastrin did not significantly affect the relaxation rate of the lower esophageal sphincter. This means that the main function of pentagastrin is to improve gastroesophageal reflux by increasing the pressure of LES, rather than by changing the relaxation rate of LES.
The effect of pentagastrin on DNA synthesis in primary cultured bovine rumen epithelial cells in vitro is mainly reflected in its promotion of cell proliferation and DNA synthesis.
Pentagastrin, as a gastrointestinal hormone, has various physiological activities, including promoting the proliferation and differentiation of gastrointestinal cells. In vitro primary culture environment, pentagastrin can stimulate the growth and proliferation of bovine rumen epithelial cells. This is mainly achieved by activating intracellular signaling pathways, thereby promoting cell cycle progression and DNA synthesis.
DNA synthesis is one of the key processes in cell proliferation. pentagastrin can increase the activity of DNA synthase in bovine rumen epithelial cells, improve the replication speed of DNA, and thus accelerate the cell proliferation process. This promoting effect helps to maintain the normal renewal and repair of rumen epithelial cells, which is of great significance for maintaining the health of the gastrointestinal tract.
The development process of pentagastrin involves multiple key steps, including compound design, synthesis, bioactivity evaluation, and clinical trials.
Design pentapeptide compounds that may have similar or stronger biological activity based on the structure and function of known bioactive substances. Screening candidate compounds with potential activity through simulation and experimentation. The synthesis process requires strict control of reaction conditions to ensure the purity and activity of the product.